NONOF:OTCMKTS
Novo Nordisk A/S
37,70 US$
arrow_downward
-1,17%(-0,44) 1D
1 tet, 12:45:54 m.d., GMT-4 · USD
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për NONOF...
Hap
35,86 US$
I lartë
38,36 US$
I ulët
35,86 US$
Kapitalizimi i tregut
128,86 mld
Vëllimi mesatar
134,15 mijë
Vëllimi
10,08 mijë
Maksimumi 52-javor
64,75 US$
Minimumi 52-javor
34,00 US$
Beta
0,63
Aksionet në qarkullim
3,39 mld
Numri i punonjësve
67 mijë
Hap
35,86 US$
I lartë
38,36 US$
I ulët
35,86 US$
Kapitalizimi i tregut
128,86 mld
Vëllimi mesatar
134,15 mijë
Vëllimi
10,08 mijë
Maksimumi 52-javor
64,75 US$
Minimumi 52-javor
34,00 US$
Beta
0,63
Aksionet në qarkullim
3,39 mld
Numri i punonjësve
67 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Business Today
·
4 orë më parë
Oral GLP-1 Drugs: Novo Nordisk, Eli Lilly Eye India Launch In 2027 | Pharma Stocks In Focus
Stock Titan
·
6 orë më parë
Wegovy cut average liver fat from 8.8% to 3.1% in 55 adults with excess liver fat over 72 weeks.
AD HOC NEWS
·
7 orë më parë
Novo Nordisk opens to New York listing while Novo Nordisk stock falls 1.10 percent
The Motley Fool
·
16 orë më parë
Novo Is Open to Acquisitions. Here Are 2 Companies That Would Be Great Candidates to Buy
Profili
Novo is a Danish multinational pharmaceutical company headquartered in Bagsværd. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds approximately 28.1% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. Wikipedia
Rreth Novo Nordisk A/S
Drejtori ekzekutivMaziar Mike Doustdar
Punonjësit66,7 mijë
Themeluar më21 dhj 1923
SeliaBagsværd, Capital Region of Denmark, Danimarkë
Sektori-
Uebsajtinovonordisk.com